ADVERTISEMENT
ADVERTISEMENT
a person in black shirt and pink pants fumigates a red brick pathway to control mosquitoes in the fight against Dengue virus.
European Medicines Agency Recommends Approving Takeda’s Dengue Vaccine
In clinical trials, the new inoculation demonstrated greater protection for children and people older than 45 than the existing dengue vaccine.
European Medicines Agency Recommends Approving Takeda’s Dengue Vaccine
European Medicines Agency Recommends Approving Takeda’s Dengue Vaccine

In clinical trials, the new inoculation demonstrated greater protection for children and people older than 45 than the existing dengue vaccine.

In clinical trials, the new inoculation demonstrated greater protection for children and people older than 45 than the existing dengue vaccine.

European Medicines Agency
Doctor holding stethoscope in front of European Union flag
New EU Protocol Aims to Improve Clinical Trial Transparency
Sophie Fessl, PhD | Feb 16, 2022 | 4 min read
A new regulation and registry covering investigational medicinal products mandates reporting and supports multinational trials.
Blood Clots a Very Rare Side Effect of AstraZeneca Vaccine: EMA
Catherine Offord | Apr 8, 2021 | 2 min read
The European Medicines Agency emphasizes that the benefits of the jab in protecting against COVID-19 still far outweigh the risks.
AstraZeneca, University of Oxford, vaccine, COVID-19, SARS-CoV-2, pandemic, coronavirus, vaccination, safety, Europe
Oxford/AstraZeneca COVID-19 Vaccine on Hold in Some Countries
Asher Jones | Mar 12, 2021 | 2 min read
Rollouts of the shot have ground to a halt following reports of blood clots, but health authorities say that these fears are unfounded and vaccination programs should continue.
Biopharma Looks to the Netherlands as European Hub
Jef Akst | Feb 1, 2021 | 7 min read
The recent move of the European Medicines Agency from London to Amsterdam is a reflection of the city’s vibrant life sciences and health sector and supporting industries.
The UK Pharmaceutical Industry Braces for Brexit
Diana Kwon | Oct 12, 2018 | 9 min read
As Britain’s departure date from the European Union approaches, drugmakers are preparing for potential changes to regulatory procedures and border controls.
European Medicines Agency to Move to Amsterdam
Shawna Williams | Nov 20, 2017 | 1 min read
A coin toss decides the agency’s post-Brexit home once it departs from London.
Drugs OKed Faster in U.S. Than in Europe
Kerry Grens | Apr 9, 2017 | 2 min read
In recent years, the US Food and Drug Administration has approved more drugs and in less time than the European Medicines Agency.
Brexit’s Effects on Science
Tracy Vence | Jun 24, 2016 | 2 min read
Researchers raise concerns related to collaboration, funding, and regulatory decisions.
EMA Gearing Up for Transparency
Kerry Grens | Jun 16, 2014 | 1 min read
The European Medicines Agency is preparing for a new policy that will release rarely-seen clinical trial reports for independent scrutiny.  
EU Considers Curbing Antibiotic Use
Chris Palmer | Jul 30, 2013 | 2 min read
The European Medicines Agency has recommended that farmers stop using the antibiotic colistin prophylactically, citing human health concerns.
Pharma Moves Toward Transparency
Chris Palmer | Jul 29, 2013 | 2 min read
The pharmaceutical industry has agreed to share data from clinical trials with researchers, patients, and the public.
Restoring Hidden Clinical Data
Dan Cossins | Jun 18, 2013 | 2 min read
Backed by two leading medical journals, researchers propose a new plan to publish clinical trial data that pharmaceutical companies often try to bury.
 
Release of Drug Data Blocked
Dan Cossins | May 2, 2013 | 1 min read
A court ruling that stops the European Medicines Agency from releasing data from two US companies calls into question the agency’s push for transparency.
Gene Therapy Arrives in Europe
Sabrina Richards | Nov 5, 2012 | 4 min read
The European Commission approves the Western hemisphere’s first gene therapy, aimed at correcting a lipid-processing disorder.
US Drug Approvals Top Canada, Europe
Megan Scudellari | May 18, 2012 | 1 min read
The FDA approves drugs faster and earlier than regulatory agencies in other countries.
Europe Watches Conflicts of Interest
Sabrina Richards | Apr 5, 2012 | 1 min read
The European Medicines Agency revised its policy on conflicts of interest in response to concerns regarding its ability to conduct independent evaluations.
ADVERTISEMENT